Jointown Pharmaceutical Co., Ltd., a prominent player in the pharmaceutical industry, is headquartered in Jinan, Shandong Province, China. Established in 1995, the company has grown significantly, expanding its operations across various regions, including Asia, Europe, and North America. Specialising in the research, development, and distribution of pharmaceuticals and healthcare products, Jointown is recognised for its extensive portfolio, which includes generic drugs, active pharmaceutical ingredients (APIs), and medical devices. The company’s commitment to quality and innovation sets it apart in a competitive market. With a strong market position, Jointown has achieved notable milestones, including strategic partnerships and a robust supply chain network. Its dedication to enhancing healthcare accessibility continues to drive its success and reputation within the global pharmaceutical landscape.
How does Jointown Pharmaceutical Co., Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Jointown Pharmaceutical Co., Ltd's score of 10 is lower than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Jointown Pharmaceutical Co., Ltd currently does not have publicly available carbon emissions data for recent years, as no specific figures have been reported. Consequently, there are no defined reduction targets or initiatives outlined in their climate commitments. In the absence of detailed emissions data, it is important to note that many companies in the pharmaceutical sector are increasingly focusing on sustainability and climate action. This often includes commitments to reduce greenhouse gas emissions across various scopes, including Scope 1 (direct emissions), Scope 2 (indirect emissions from energy consumption), and Scope 3 (indirect emissions from the supply chain). While Jointown Pharmaceutical has not disclosed specific targets or achievements related to carbon emissions, the industry trend suggests a growing emphasis on environmental responsibility and the adoption of science-based targets to mitigate climate impact.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jointown Pharmaceutical Co., Ltd is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.